INTRODUCTION

The world’s ageing population is growing fast, and the population of older people is projected to reach 2.1 billion in the next three decades.1 Similar trend of increasing elderly population has been observed in developed and developing countries, including the sub-Saharan African (SSA) region.1 Although the population of older people aged 60 years in SSA constitutes less than 10% of the total population, a rapid demographic shift has been observed in this region - doubling the number of older people in some developed regions such as northern Europe by 2050.2 By 2050, the population of older people in SSA is estimated to reach 163 million,2 implying that more people will live longer than in previous generations. However, in this region, widespread poverty, lack of social security, and poor health outcomes characterize the living condition of the average older adult and hinder successful and healthy ageing.1 Hence, strategies to address these issues are needed to prepare for the impending elderly population growth.

Despite the anticipated problems posed by the demographic shift, little consideration has been given to ageing research in SSA.3 Compared to the global north, the scarcity of data or research limits the formulation of viable policies to prepare the SSA countries for the future needs of the growing elderly population.4 However, efforts have encouraged research in the SSA region. Such efforts include, but are not limited to, stakeholders meetings organized by the National Institute in Ageing to advance ageing research in Africa in 20044; establishing data collection centres for the Study of Global Ageing and Adult Health in three SSA countries – Ghana, South-Africa and Uganda (SAGE)5; and recently Emerging Researchers & Professionals in Ageing-African network’s articles on setting priorities for ageing research in the SSA.6 The latter group conducted a systematic mapping review of 512 ageing peer-reviewed studies, predominantly quantitative cross-sectional studies with a greater percentage of the included articles focused on HIV/AIDs, noncommunicable disease and cancer, followed by studies on the physical functioning of the older adults.6 Another important finding from this review was that studies, regardless of study design, increased tremendously over a decade, 316% increase for quantitative studies, 293% for qualitative, and 300% for mixed-method studies.6 While this proliferation of studies is a welcome development in preparation for the projected increase in the older adult population in the SSA region, little is known about the quality of these studies.

Quality assessment (also called quality appraisal or critical appraisal) systematically examines research evidence to assess its validity and relevance before using it for decision-making.7 As Sanderson et al.8 described, quality is an amorphous concept that typically entails two components: quality of reporting and methodology (i.e., what was done in a study’s design, conduct, and analysis) in research. Examples of methodological qualities include bias assessment, such as selection, performance, detection, attrition, and reporting selective biases; tools have been designed to assess these qualities.9 Reporting quality describes how well an article is written, often in a simple checklist.9 The EQUATOR (Enhancing the QUAlity and Transparency Of health Research) network described reporting guidelines are tools designed to ensure accurate, complete, and transparent reporting of research studies to support research productivity and usefulness.10 They have registered 256 guidelines on various health and social research study designs.11,12 Methodology reporting is often challenging, especially when there is a poor quality of reporting. Therefore, authors are encouraged to assess articles with a tool containing sections for reporting and methodology quality, e.g., Downs & Black Checklist.13 In summary, the quality assessment provides information on the overall strength of evidence and methodological quality of a research design, highlighting the level of confidence the reader should place on the findings for decision making.

Appraisal of the methodological characteristics of ageing studies in SSA could help determine the strengths and weaknesses of these studies and how they could impact evidence and recommendations. High-quality empirical research is needed in SSA to know the current situation of older people, improve quality of life, promote healthy ageing, and inform policies. Therefore, this study aimed to assess the quality of studies on ageing in SSA.

METHODS

This paper is the second in a four-part series that aims to set priorities for ageing research in the SSA.6 The detailed methodology of the mapping review has been published elsewhere.6 Summarily, this paper followed Grant and Booth’s14 description of a mapping review to categorize existing literature to commission further reviews and/or primary research by identifying gaps in the literature. The quality of existing literature is essential to identify the literature gaps and possibly commission further studies.

Search strategy, study selection, and data extraction

Comprehensive search strategy, study selection and data extraction have been published elsewhere.6 Summarily, we searched seven databases, including PubMed, Excerpta Medica database (EMBASE), Cumulative Index to Nursing and Allied Health Literature (CINAHL), PEDRO (physical evidence database), Cochrane CENTRAL, PsycINFO and Web of Science, using medical subheadings (MeSH) in two concepts - Ageing and countries in Africa. The last search in the Kalu et al.6 was in February 2021, and we updated our search till December 2021. We included qualitative, quantitative or mixed-method studies focusing on older adults (55 years and older – 55years is considered to be older in the SSA region15), either directly (research conducted with or for older adults) or indirectly (e.g., studies that explored the experience of healthcare workers and students in providing care to older adults) (for full inclusion and exclusion criteria see Kalu et al.6). Multiple reviewers selected data (title/abstract/full-text screening) using predefined inclusion and exclusion criteria and extracted study data. Any disagreement was resolved in research meetings.

Current paper methodology – Quality assessment of the included studies.

This current study focused on the quality assessment of the articles in Kalu et al.'s6 review and articles retrieved from an updated search. Different tools were used for the quality assessment of the included studies. While the Down and Black Checklist was used to assess the quantitative studies,13 Case reports were assessed using Case Report (CARE) guidelines checklist.16 A 45-items tool described by Lundgren et al.17 was used to assess the qualitative studies, and mixed-method studies were assessed using the Mixed Methods Appraisal Tool (MMAT).18

Quantitative studies. The methodological and quality reporting of randomized controlled trials was rated using the Downs and Black Checklist (maximum score 28) and non-randomized trials using a modified checklist version (maximum score 24).13 The original checklist is comprised of 27 items over five domains [reporting (n=10 items), external validity (n=3), internal validity-bias (n=7), interval validity-cofounding (n=6), and power (n=1)]. Each item was rated as 0 (no or unable to determine) or 1 (yes), except for item 5, which was rated as 0 (no), 1 (partially), or 2 (yes).13 Articles received a score of 0 on the Power domain if the sample size was <300 based on population-based calculation for cross-sectional studies19 or if the authors did not state a prior sample size calculation for Randomized control trials (RCTs), to ensure that the study was adequately powered. The original version was used to rate the quality of RCTs and quasi-experimental studies, while the modified version20 was used to rate cross-sectional, longitudinal studies and case-control studies. See Table 1 for modifications and scoring.21

Table 1.Downs and Black Checklist scoring modifications for each study type
Study type Maximum score Excellent Good Fair Poor
*RCT and Quasi -experimental studies 28 23 – 28 17 – 22 12 – 16 <12
#Case control and Longitudinal studies 24 19 – 24 13 – 18 8 – 12 <8
#Cross-sectional studies 23 19 – 23 13 – 18 8 – 12 <8

*The original checklist consists of 27 items, with each item rated as 0 (no or unable to determine) or 1 (yes), except for item 5, which was rated as 0 (no), 1 (partially), or 2 (yes), resulting in a maximum score of 28, was used to assess the quality of Randomised control trial (RCT) and quasi-experimental studies.13
# The modified version removed some items, adapting them for case-control longitudinal studies and cross-sectional studies.20 For cohort and case-control studies, three questions from the internal validity – bias section [blinding of subjects, blinding of assessors, and compliance with intervention] and two questions from the Internal validity – confounding section [randomization assignment concealed from both patients and interventionists, and accounting for losses to follow-up due to intervention] were removed, resulting in a maximum score of 24. For cross-sectional, additional item [analyses adjusted for different lengths of follow-up] was removed from the internal validity – bias selection, resulting in a maximum score of 23. The scoring was adapted from Hooper et al.21).

Case report studies. The quality of reporting of case reports or case series was assessed using the CAse REport (CARE) guidelines checklist,16 consisting of 31 items, which was rated as 0 (no - if the item is not identified in the report) or 1 (yes - if the item is identified in the description); the highest possible score is 31. We rated the quality of reporting of the included studies as high (26-31), moderate (20-25), and >20 (poor).

Qualitative studies. We assessed the quality of the included studies using a 45-items tool previously described by Lundgren et al.17 We chose this tool because it provides additional items such as ethical issues, audit mechanism, relevance and transferability lacking in some other checklists used in assessing the quality of qualitative studies (e.g., Consolidated criteria for reporting qualitative research 32-item checklist). The Lundgren et al.'s17 45 items composite grid checklist has five domains: research team and reflexivity (8-items), scope and purpose (2-items), study design (17-items), analysis and findings (14-items), and relevance and transferability (4-items). We rated all 45-items as 0 (no or not applicable) or 1 (yes); the highest possible score is 45. We rated the quality of the included studies as high (39-45 points), moderate (31-38) and low (≤30).17

Mixed-method studies. The Mixed Methods Appraisal Tool (MMAT), developed in 2006 and last revised in 2018,18 was used to appraise the methodology qualities of the mixed-method studies. The tool consists of 6 sections with related questions, of which assessors are required to answer – “Yes”, “No”, or “Can’t tell” with an option of writing a comment. Each of the six sections (qualitative, quantitative-RCT, quantitative-non-RCT, quantitative descriptive and mixed method) contains five questions, except the screening question has only two questions. For each study, we choose the appropriate quantitative study design and the qualitative study to appraise, in addition to the five questions mixed-method section. The five questions for mixed-method were grouped into Justification - Is there an adequate rationale for using a mixed-methods design to address the research question?; Integration - Are the different components of the study effectively integrated to answer the research question?; Interpretation - Are the outputs of integrating qualitative and quantitative components adequately interpreted?; Disagreements - Are divergences and inconsistencies between quantitative and qualitative results adequately addressed?; and, Adherence - Do the different components of the study adhere to the quality criteria of each tradition of the methods involved? For a sample of the MMAT, see http://mixedmethodsappraisaltoolpublic.pbworks.com/w/file/fetch/127916259/MMAT_2018_criteria-manual_2018-08-01_ENG.pdf. The overall numerical scoring of the MMAT is discouraged because it is less informative and fails to show the aspects of articles (qualitative vs quantitative) that are problematic.18 Instead, MMAT developers recommended that authors report the quality of each study design and the mixed method component and describe each study as a low or high MMAT studies. We classify a component (qualitative or quantitative) as low if they ≤ 60% of the MMAT criteria (i.e., if ≤ three questions were yes), and high if they > 60% (i.e., more than three questions were yes); this classification has been used previously.22

The procedure of the quality assessment

We grouped reviewers based on their experience in quality assessment of quantitative, qualitative, or mixed-method studies. Author-reviewers were placed in each group based on their years of experience and the number of authorships in systematic review publications. That notwithstanding, we (Emerging Researchers & Professionals in Ageing - African Network - www.erpaan.org) conducted a two-day refresher training for all reviewers. Twenty-six author reviewers participated in the quality assessment of the included article. Because of the large volume of quantitative studies, 20 reviewers were assigned to assess the quality of RCTs and pre-post studies (n=2), longitudinal studies (n=4), case-control studies (n=2), cross-sectional studies (n=10), and case report (n=2). The remaining six reviewers assessed the quality of qualitative studies (n=4) and mixed-method studies (n=2). We performed pilot testing of the quality assessment of each study design, and the inter-rater reliability ranged from 0.78 to 0.87 across the groups, indicating a moderate to the high magnitude of agreement amongst raters.23 Because we could not get a uniform agreement among raters in the pilot testing, the quality assessment for each study design was done in pairs. Summarily, two raters independently rated: 15 RCTs and pre-post studies, 56 longitudinal studies, 14 case-control studies, 60 cross-sectional studies, 4 case reports, 37 qualitative studies, and 15 mixed-method studies. The mean score of the raters was used as the final rating, provided the rating was in the same category. For instance, rater1 total score for an RCT based on the Down and Black Checklist13 is 18, and rater2 scored 20 for the same study. The mean scores of rater1 and rater2 are reported because both scorings are within the scoring classified as good [17 - 22] in the Down Black Checklist.13 A third rater assessed the same articles if two raters’ scores were not in the same category. Across all studies, a third rater was involved in only ten cross-sectional studies. The mean score of two out of the three raters in the same category was reported.

Data extraction and synthesis

We extracted the meta-data of the included articles: the countries in which each study was conducted, the study design, study settings, sampling method and recruitment strategies, participants’ characteristics (sample size, sex, age), data analysis method and the main findings, and these were analyzed using descriptive statistics, such as mean and standard deviation (for continuous variables), median, interquartile range (for categorical variables), frequencies, and percentages. This information has been presented elsewhere.6 The inter-rater reliability - the level of agreement between raters for quality assessment of the included articles,23 was calculated using Kappa statistics. Values ranged from less than 60 (weak) 0.60 - 0.79 (moderate), 0.80 - 0.90 (strong) and Above 90 (almost perfect).23 Each range was calculated using frequency count and percentages. We perform all data analysis in STATA (c).

RESULTS OF THE QUALITY ASSESSMENT

Additional 32 articles were added to the original 512 articles, totalling 544. Article type include: RCTs and pre-post (n=15), longitudinal (n=122), case-control (n=14) and cross-sectional (n=300); 4 case reports; 74 qualitative studies and 15 mixed-method studies. Studies were conducted 23 countries include South Africa (241, 44.3%), Nigeria (n=88, 16.2%), Ghana (n=53, 9.7%), Uganda (n=32, 5.9%), Tanzania (n=26, 4.8%), Kenya (n=24, 4.4%). Other studies were conducted: Cameroon, Central Africa Republic (9 studies); Senegal (6 studies); Malawi (5 studies); Burkina Faso (4 studies); Angola, Ethiopia, Zimbabwe (3 studies); Democratic Republic of Congo, Gambia (2 studies) and Benin, Eswatini, Namibia, Rwanda, Zambia (one each); and more than one African countries (25 studies). See Appendix A for a complete reference list of all the included articles.

Quality assessment of quantitative studies. Details of the quality assessment for RCT and quasi-experimental studies (n=15) can be found in Table 2. Only one was rated as excellent.24 Four studies were rated as good,25–28 eight as fair,29–36 and the remaining two as poor quality.37,38 Table 3 provides the quality assessment results of the 122 longitudinal studies. We rated 27 studies as excellent, 71 studies as good, 20 as fair,39–58 and three as poor quality.59–61 The quality assessment for the 14 case-control studies is described in Table 4. We rated four articles as excellent,62–65 five as good,66–70 and five as fair.70–74 Out of the 300 cross-sectional studies, 48 were rated as excellent, 171 as good, 63 as fair, and 18 as poor quality75–92 (see Table 5). Among the 49 studies rated as excellent, only three studies have insufficient power to detect a clinically meaningful effect.93–95

Table 2.Quality Assessment of Randomised control trial and Quasi- experimental studies (n = 15) using the original version of Down & Black checklist.13
S/N Authors, year of publication, country Reporting /11 External Validity /3 Internal Validity - Bias /7 Internal Validity - Confounding /6 Sufficient power to detect a clinically important effect / 1 TOTAL/28 Interpretation
1 Abelson. (2013). South Africa. 5 1 3 1 0 10 Poor
2 Adam. (2013). South Africa. 7 1 5 2 0 15 Fair
3 Boon et al. (2009). South Africa. 7 1 5 3 0 16 Fair
4 De Villiers et al. (2009). South Africa 9 1 7 5 1 23 Excellent
5 Ezenwa et al. (2020). Nigeria. 7 1 7 4 0 19 Good
6 Forrest et al. (2011). South Africa. 9 1 5 4 1 20 Good
7 Geerts. (2017). South Africa. 8 1 5 4 0 18 Good
8 Geffen et al. (2019). South Africa. 5 0 5 1 0 11 Poor
9 Rayner et al. (2012). South Africa. 7 1 5 2 0 15 Fair
10 Nanji, et al. (2020). Kenya 5 3 6 3 1 18 Good
11 Nwankwo et al. (2020). Nigeria. 6 1 4 3 0 14 Fair
12 Puckree et al. (2014). South Africa. 7 3 3 2 1 16 Fair
13 Skidmore et al (2015), South Africa 7 1 3 3 0 14 Fair
14 Vorobiof et al. (2004). South Africa. 8 0 5 2 0 15 Fair
15 Webb et al. (2015). South Africa. 5 1 3 2 1 12 Fair
Table 3.Quality Assessment of Longitudinal studies (n = 122) using a modified version of Down & Black Checklist.13
S/N Authors, year of publication, country Reporting /11 External
Validity/3
Internal Validity -Bias /4 Internal Validity – Confounding /4 Sufficient power to detect a clinically important effect / 1 TOTAL /24 Interpretation
1 Adhavaryu et al. (2012). Tanzania 11 2 3 3 1 20 Excellent
2 Akinyemi et al. (2017). Nigeria 11 1 3 4 1 20 Excellent
3 Alberts et al. (1991). South Africa 11 1 2 3 0 17 Good
4 Ardington et al. (2010). South Africa. 5 3 1 2 1 12 Fair
5 Asiimwe et al. (2020). South Africa 6 3 2 3 1 14 Good
6 Bastawrous et al. (2016). Kenya 7 2 2 3 1 15 Good
7 Beaugé et al. (2020). Burkina Faso 9 3 2 4 1 19 Excellent
8 Bennett et al. (2016). Kenya 7 3 2 2 1 15 Good
9 Biritwum et al. (2013). Ghana 6 3 2 2 1 14 Good
10 Charlton et al. (2021). South Africa 10 2 2 2 1 18 Good
11 Chepngeo-Langat et al. (2011). Kenya 10 2 2 2 1 17 Good
12 Chepngeo-Langat et al. (2021). Kenya 11 2 2 3 1 19 Excellent
13 Chepngeo-Langat. (2014). Kenya 10 2 2 2 1 17 Good
14 Clark et al. (2014). USA and Nigeria. 11 3 2 2 1 19 Excellent
15 *De Terline et al. (2020). Several countries 11 2 3 2 1 20 Excellent
16 Dewhurst et al. (2012). Tanzania. 11 2 2 2 1 18 Good
17 Dia et al. (2014). Senegal. 11 3 2 3 1 20 Excellent
18 Digenio et al. (1991). South Africa 9 2 1 3 1 16 Good
19 Dotchin et al. (2015). Tanzania 11 2 2 3 1 22 Excellent
20 Eduardo et al., (2014). Kenya, Tanzania, Mozambique, Rwanda. 7 1 3 2 1 14 Good
21 Fantahun, Berhane, Högberg, Wall & Byass (2009). Ethiopia 5 1 2 1 1 10 Fair
22 ~Ferrari et al., (2015). Several countries 10 0 2 1 1 15 Good
23 Gaziano et al., (2017), South Africa. 10 2 1 2 1 16 Good
24 Gray et al., (2014). Tnazania 8 2 3 0 1 14 Good
25 Gray et al., (2016). Tanzania. 8 3 3 2 1 18 Good
26 Gray et al., (2017). Tanzania 8 2 3 1 1 16 Good
27 Gureje, et al. (2006). Nigeria 8 2 2 1 1 14 Good
28 Gureje, et al. (2011a). Nigeria. 9 2 2 1 1 15 Good
29 Gureje, et al. (2011b). Nigeria. 10 2 2 2 1 17 Good
30 Gureje, et al. (2014). Nigeria. 10 2 2 1 1 16 Good
31 Gyasi, et al. (2019). Ghana 8 0 2 1 1 12 Fair
32 Hendrie et al. (2013). Nigeria and USA. 9 2 2 2 1 15 Good
33 Heyns, et al. (2003). South Africa. 6 1 2 2 1 13 Good
34 Hosegood and Timaeus. (2005). South Africa. 9 2 2 2 1 16 Good
35 Ice et al. (2008). Kenya 6 0 2 1 0 9 Fair
36 Ice, et al. (2010). Kenya 10 0 2 2 1 15 Good
37 Ice, et al. (2012). Kenya 10 0 2 2 1 15 Good
38 Jardim et al. (2018). South Africa. 8 1 2 2 1 13 Good
39 Kalula et al. (2006). South Africa. 9 1 2 1 1 13 Good
40 Kalula et al. (2010). South Africa. 2 1 1 1 1 13 Poor
41 Kalula et al. (2015). South Africa. 5 2 2 2 1 12 Fair
42 Kalula et al. (2016). South Africa. 8 3 2 3 1 18 Good
43 Kalula et al. (2017). South Africa. 9 2 2 2 1 14 Good
44 Karstaedt & Bolhaar. (2014). South Africa. 2 1 1 0 0 15 Poor
45 Kretchy et al. (2020), Ghana 10 1 1 1 0 12 Fair
46 Lartey et al. (2019). Ghana 9 2 3 3 1 18 Good
47 Lasisi et al. (2010). Nigeria. 10 0 3 4 1 18 Good
48 Lasisi & Gureje (2014). Nigeria 8 3 3 3 1 18 Good
49 Lazenby et al. (2012). Botswana 9 0 3 3 1 16 Good
50 Menyanu et al. (2017). Ghana and South Africa. 6 1 3 1 1 13 Good
51 Menyanu et al. (2021). Ghana and South Africa. 6 1 3 1 1 13 Good
52 #Moreno-Agostino et al. (2020). Several countries 7 2 2 3 1 16 Good
53 Namale, et al. (2020). Uganda 8 3 3 2 0 17 Good
54 Ojagbemi et al. (2015). Nigeria 10 3 3 4 1 21 Excellent
55 Ojagbemi et al. (2016). Nigeria 10 3 3 4 1 21 Excellent
56 Ojagbemi et al. (2017a). Nigeria 10 3 3 4 1 21 Excellent
57 Ojagbemi et al. (2017b). Nigeria 10 3 3 4 1 21 Excellent
58 Ojagbemi et al. (2018). Nigeria 10 3 4 4 1 23 Excellent
59 Okunade et al. (2020). Nigeria 11 3 3 4 0 21 Excellent
60 Ologe et al. (2005). Nigeria 6 0 3 3 1 13 Good
61 Onakpoya et al. (2020). Nigeria. 10 0 3 3 1 17 Good
62 Onwubiko et al. (2020). Nigeria. 10 3 2 3 0 18 Good
63 Oshi et al. (2014). Nigeria 11 3 3 4 1 22 Excellent
64 Otitoola et al. (2015). South Africa 11 3 3 4 0 21 Excellent
65 Paddick et al. (2017). Tanzania. 11 0 3 4 0 18 Good
66 Parag and Buccimazza. (2016). South Africa. 5 1 0 3 0 9 Fair
67 Payne et al. (2013). Malawi. 6 2 1 2 1 12 Fair
68 Payne et al. (2017). South Africa. 6 3 2 2 1 14 Good
69 Puckree. (2002). South Africa. 4 1 2 1 1 9 Fair
70 Pupwe et al. (2020). Zambia. 6 2 2 2 1 13 Good
71 Putnam et al. (2018). Tanzania 7 2 2 3 1 15 Good
72 Ralston et al. (2019). South Africa 6 3 3 3 1 16 Good
73 Ramlall et al. (2014). South Africa 6 2 2 1 1 12 Fair
74 Rand et al. (2015). South Africa 7 1 3 1 0 12 Fair
75 Reiger et al. (2017). South Africa 7 3 2 2 1 15 Good
76 Rishworth et al. (2020). Uganda 6 3 2 2 1 15 Good
77 Rohr et al. (2017). South Africa. 6 2 0 1 0 9 Fair
78 Rosenberg et al. (2020). South Africa. 5 2 2 1 1 11 Fair
79 Segal et al. (1982). South Africa 2 1 0 0 0 3 Poor
80 Sanuade et al. (2019). Ghana 5 2 2 0 0 9 Fair
81 Sanya et al. (2011). Nigeria. 4 2 1 0 1 9 Fair
82 Schatz et al. (2018). South Africa 7 2 2 1 1 13 Good
83 Simiyu et al. (2021). South Africa 9 2 2 1 1 14 Good
84 Sissolak et al. (2013). South Africa 7 1 3 3 0 14 Good
85 Sliwa et al. (2010). South Africa 10 3 3 2 0 18 Good
86 Solomon et al. (2005). South Africa. 9 3 2 1 1 16 Good
87 Solomon. (1984). South Africa. 5 1 2 1 0 9 Fair
88 Swart et al. (2014). South Africa 8 2 2 3 0 15 Good
89 Tomita & Burns. (2013). South Africa 9 3 3 1 1 16 Good
90 Torgersen et al. (2019). Botswana 11 3 3 2 1 20 Excellent
91 Udjo. (2006). South Africa. 5 2 1 0 1 9 Fair
92 van der Wielen et al. (2018). Ghana 11 2 3 2 1 19 Excellent
93 van Staden & Weich. (2007). South Africa. 6 2 3 2 0 13 Good
94 Vlantis, Gregor, Elliot & Oudes. (2003). South Africa 10 0 3 4 0 18 Good
95 von Klemperer, Bateman, Owen & Bryer. (2014). South Africa 8 2 3 4 0 18 Good
96 Vorster et al. (2015). South Africa 10 0 3 3 0 17 Good
97 Wachira & Tyler. (2015). Kenya. 9 2 3 3 0 18 Good
98 Walker & Walker. (2005). South Africa. 8 2 3 3 1 18 Good
99 Walker et al. (1986). South Africa. 9 3 3 3 0 19 Excellent
100 Wallrauch, Bärnighausen & Newell. (2010). South Africa 9 3 3 4 1 20 Excellent
101 Ware et al. (2017). South Africa 10 3 3 4 1 21 Good
102 Wasserman & Bryer. (2012). South Africa 9 2 3 4 0 19 Excellent
103 Wasserman, Apffelstaedt & Odendaal. (2007). South Africa. 9 2 3 4 1 20 Excellent
104 Wasserman, de Villiers & Bryer. (2009). South Africa 9 3 3 4 0 20 Excellent
105 Waterhouse, van Der Wielen, Banda & Channon (2017). South Africa. 9 3 3 4 1 20 Excellent
106 Wentink et al. (2010). South Africa. 9 3 3 4 0 20 Excellent
107 Westaway, Jordaan, & Tsai. (2015). South Africa 10 3 3 4 1 21 Excellent
108 Westaway, Olorunju & Rai. (2007). South Africa 9 3 3 4 1 20 Good
109 Westaway, Rheeder, & Gumede. (2001). South Africa 9 3 3 4 1 20 Excellent
110 Westaway. (2010b). South Africa 10 0 3 4 1 18 Good
111 Whitelaw et al. (1992). South Africa. 4 0 2 2 0 8 Fair
112 Whittaker et al. (1991). South Africa. 5 0 2 1 1 9 Fair
113 Whittaker et al. (1991). South Africa. 5 0 2 1 1 9 Fair
114 Wood et al. (2007). South Africa. 6 3 2 3 0 14 Good
115 Yawson et al. (2013). Ghana 6 3 2 2 1 14 Good
116 Yawson et al. (2014). Ghana 6 3 2 2 1 14 Good
117 Yoro-Zohoun et al. (2019). Central Africa 7 3 2 2 1 15 Good
118 Yoro-Zohoun et al. (2019). Central Africa Republic & Republic of Congo 7 3 2 2 1 15 Good
119 Yorston et al. (2002). Kenya 6 3 2 3 1 15 Good
120 Zengin et al. (2017). Gambia 7 3 2 3 1 16 Good
121 Zengin et al. (2018). Gambia 7 3 2 3 1 16 Good
122 Zwi et al. (1989). South Africa. 6 3 2 3 1 15 Good

*= Benin, Cameroon, Congo, D.R Congo, Gabon, Guinea, Cote d’Ivoire, Mauritania, Mozambique, Niger, Senegal, Togo; #= China, Ghana, India, Mexico, South Africa, Finland, Poland, Spain; ~= Western/Central Europe; Canada/South Africa/Australia/UK; Eastern Europe; Central/South America; Middle East; East Asia; and India.

Table 4.Quality Assessment of Case-control studies (n = 14) using a modified version of Down & Black Checklist.13
S/N Authors, year of publication, country Reporting / 11 External Validity /3 Internal validity – Bias /4 Internal -Cofounding /4 Sufficient power to detect a clinically important effect /1 TOTAL /24 Interpretation
1 Adebajo et al (1991). Nigeria. 9 3 3 3 1 19 Good
2 Akinyemi et al. (2014). Nigeria 11 2 4 3 0 20 Excellent
3 Ayuk et al. (2020). Nigeria. 6 0 3 2 1 12 Fair
4 Bloomfield et al. (2016). Kenya. 8 0 4 3 1 16 Good
5 Diamond et al (1986). South Africa 11 3 2 3 1 20 Excellent
6 Meiring et al. (1983). South Africa 10 1 3 4 0 18 Good
7 Schnaid et al. (2000). South Africa 6 2 2 1 0 11 Fair
8 Segal et al. (1988). South Africa. 5 3 2 0 0 10 Fair
9 Solomon et al. (2011). South Africa. 8 1 2 3 1 15 Good
10 van Vuuren, Rheeder & Hak (2009). South Africa 10 3 4 4 1 22 Excellent
11 Walker et al (1989). South Africa 6 1 4 2 0 13 Good
12 Walker et al (1992). South Africa 10 3 3 2 1 19 Excellent
13 Whigham et al (2011). South Africa 4 1 3 2 0 10 Fair
14 Williams et al (2010). South Africa. 6 1 3 2 0 12 Fair
Table 5.Quality Assessment of Cross-sectional studies (n = 300) using modified version of Down & Black checklist.13
S/N Authors, year of publication, country Reporting / 11 External Validity
/ 3
Internal Validity – Bias
/ 3
Internal Validity – Confounding /4 Sufficient power to detect a clinically important effect / 1 TOTAL/ 23 Interpretation
1 Abbai et al. (2018). South Africa 11 0 2 2 1 16 Good
2 Abene et al. (2020). Nigeria 11 1 3 2 1 18 Good
3 Aboderin et al. (2017). Kenya 9 2 3 2 1 17 Good
4 Ackuaku et al. (2015). Ghana 11 1 3 3 0 18 Good
5 Adebusoye et al (2018). Nigeria 11 1 3 3 1 19 Good
6 Agboghoroma et al (2020). Nigeria 10 1 3 3 0 17 Good
7 Agbozo et al. (2018). Ghana 9 2 1 1 0 13 Good
8 Aheto et al. (2020). Ghana 11 3 3 3 1 21 Excellent
9 Akande-Sholabi et al. (2020). Nigeria 11 2 3 2 0 18 Good
10 Akande-Sholabi et al. (2020). Nigeria 9 2 3 3 1 18 Good
11 Akinyemi et al. (2008). Nigeria 11 0 2 1 1 15 Good
12 Akinyemi et al. (2017). Nigeria 11 0 3 3 0 17 Good
13 Akinyemi et al. (2014). Nigeria 9 1 3 3 1 17 Good
14 Akinyemi et al. (2015). Nigeria 11 1 3 2 0 16 Good
15 Akor et al. (2020). Nigeria 11 3 3 3 0 20 Excellent
16 Akosile et al. (2014). Nigeria 11 1 3 2 0 17 Good
17 Akosile et al. (2018). Nigeria 11 0 3 2 0 16 Good
18 Akosile et al. (2021). Nigeria 11 0 3 2 0 16 Good
19 Akuamoah et al. (2013). Ghana 11 3 2 2 1 19 Excellent
20 Allain et all. (2014). Malawi 10 0 2 2 0 14 Good
21 Amegbor et al. (2018). Ghana 7 3 2 2 1 15 Good
22 Amegbor et al. (2020). Ghana 7 3 1 2 1 14 Good
23 Ameh et al. (2014). South Africa 5 0 2 2 1 10 Fair
24 Amoo et al. (2020). Nigeria 6 0 2 2 1 11 Fair
25 Amosun et al. (2007). South Africa 6 0 1 3 0 10 Fair
26 Amosun et al. (2014). South Africa 5 0 2 2 0 9 Fair
27 Annin et al. (2014). Ghana 5 3 2 2 1 13 Good
28 Asiamah et al. (2019). Ghana 6 0 2 2 1 11 Fair
29 Awoke et al. (2017). Ghana 6 3 2 3 1 15 Good
30 Awuviry-Newton et al. (2020). Ghana 7 0 2 2 1 12 Fair
31 Awuviry-Newton et al. (2020). Ghana 5 0 2 2 1 10 Fair
32 Ayernor, P.K. (2012). Ghana. 6 0 2 2 1 11 Fair
33 Ayodapo et al. (2020). Nigeria. 7 0 2 3 1 13 Good
34 Balogun et al. (2018). Nigeria. 6 3 2 2 1 14 Good
35 Bello et al. (2019). Nigeria. 6 0 2 2 1 11 Fair
36 Boateng et al. (2017). Ghana 5 3 2 2 1 12 Fair
37 Boateng et al. (2021). Ghana 11 3 3 4 1 22 Excellent
38 Bolaji et al. (2021). Nigeria 5 0 2 2 0 9 Fair
39 Bomman & Reif. (2007). South Africa 2 0 0 0 0 2 Poor
40 Boon et al. (2010). South Africa 5 0 2 2 1 10 Fair
41 Brathwaite et al. (2002). South Africa 5 0 2 2 0 9 Fair
42 Cadmus et al. (2017). Nigeria. 6 0 2 2 1 11 Fair
43 Callixte et al. (2015). Cameroun. 6 0 2 2 1 11 Fair
44 Calys-Tagoe et al. (2014). Ghana 11 3 2 2 1 20 Good
45 Calys-Tagoe et al. (2020). Ghana 6 3 2 2 1 13 Good
46 Charlton et al. (2007). South Africa 11 3 2 2 1 20 Excellent
47 Chepngeo-Langat et al. (2012). Kenya 11 2 2 3 1 19 Excellent
48 Chepngeo-Langat et al. (2019). Kenya 11 2 2 2 1 18 Good
49 Chepngeo-Langat. (2013). Kenya 10 2 2 3 0 17 Good
50 Chilima et al. (1991). Malawi. 11 2 2 2 1 17 Good
51 Chilima et al. (2001). Malawi. 11 3 2 2 1 18 Good
52 Chukwuorji et al. (2017). Nigeria. 11 3 2 4 1 22 Excellent
53 Clausen et al. (2005). Botswana 11 2 2 2 1 18 Good
54 Dake and Van der Wiolen. (2020). Ghana. 11 3 3 3 1 21 Excellent
55 De Jager et al. (2017). South Africa. 11 2 2 3 1 19 Excellent
56 De Picciotto & Friedland. (2001). South Africa 5 0 2 2 0 9 Fair
57 De Rouvray et al. (2014). Central Africa 7 3 2 2 1 15 Good
58 De Villiers et al. (2011). South Africa 6 0 2 2 0 9 Fair
59 Dei and Sebastian. (2018). Ghana. 11 3 3 3 1 21 Excellent
60 Desomais et al. (2015). Central Africa Republic & Republic of Congo 7 3 2 2 1 15 Good
61 Dewhurst et al. (2012a). Tanzania. 11 2 2 2 1 18 Good
62 Dewhurst et al. (2012b). Tanzania. 11 3 2 2 1 19 Excellent
63 Dewhurst et al. (2013a). Tanzania 10 3 3 3 1 20 Excellent
64 Dewhurst et al. (2013b). Tanzania 10 3 3 2 1 19 Excellent
65 Dewhurst et al. (2014). Tanzania 6 3 2 2 1 14 Good
66 Dobsene et al. (2020). Cameroon. 11 3 2 3 1 22 Excellent
67 Drah, B.B. (2014). Ghana. 11 3 2 3 1 20 Excellent
68 Dur and Engelbrocht. (2001). South Africa 11 3 2 3 1 21 Excellent
69 Eales & Stewart (1996). South Africa 8 1 2 1 0 12 Good
70 Eales & Stewart (1997). South Africa 8 1 2 1 0 12 Fair
71 Elk, Swartz & Gillis (1983). South Africa 5 2 1 1 1 10 Fair
72 Enikuomehin et al. (2020). Nigeria 10 2 3 1 1 17 Good
73 Eze, Mbaeri & Orakwe (2020). Nigeria 7 2 3 2 0 14 Good
74 Faber et al., (1992). South Africa. 4 3 3 1 0 11 Poor
75 Fakoya et al., (2018). Nigeria 9 2 2 2 0 14 Good
76 Fawale, et al. (2017). Nigeria 10 2 3 2 1 17 Good
77 Folorunso et al., (2020). Nigeria 8 2 2 1 0 13 Good
78 Gildner et al. (2014). China, Ghana, India, Mexico, Russian Federation, and South Africa 6 2 2 0 1 11 Fair
79 Gillis (1981). South Africa. 5 3 2 1 0 11 Fair
80 Gillis, Welman, Koch & Joyi (1991). South Africa 5 3 2 1 1 12 Fair
81 Goehler et al. (2018). Uganda 11 1 2 4 1 19 Excellent
82 Golaz, Wandera, & Rutaremwa (2017). Uganda 3 1 1 0 0 5 Poor
83 Gómez-Olivé et al. (2014). South Africa 9 3 3 2 1 19 Excellent
84 Gómez-Olivé, et al. (2013). South Africa 9 3 3 1 1 17 Good
85 Govender & Barnes (2014). South Africa 5 2 2 2 1 12 Fair
86 Guerchet et al., (2009). Benin/West Africa 10 2 3 2 1 18 Good
87 Guerchet et al., (2010). Central Africa 10 2 3 2 1 18 Good
88 Guerchet et al., (2012). Central Africa 10 2 2 2 1 17 Good
89 Guerchet et al., (2013). Central Africa 10 2 2 2 1 17 Good
90 Gureje, Ademola & Olley (2008). Nigeria 7 2 1 2 1 13 Good
91 Gureje, et al. (2006). Nigeria 9 2 2 2 1 16 Good
92 Gureje, et al. (2007). Nigeria 9 2 2 2 1 16 Good
93 Gutiérrez, et al. (2014). Angola 9 1 2 0 1 13 Good
94 Gyasi, et al. (2018a). Ghana 9 2 2 1 1 14 Good
95 Gyasi, et al. (2018b). Ghana 9 2 2 1 1 15 Good
96 Gyasi, et al. (2020a). Ghana 9 1 2 0 1 15 Good
97 Gyasi, et al. (2020b). Ghana 8 0 2 2 1 13 Good
98 Gyasi, et al. (2020c). Ghana 8 2 2 1 1 13 Good
99 Gyasi, et al. (2020d). Ghana 8 2 2 1 1 14 Good
100 Gyasi, et al. (2020e). Ghana 9 2 2 1 1 15 Good
101 Hao, et al. (2017). South-Africa 9 2 2 1 1 15 Good
102 Harris, et al. (2021). Eswatini 8 0 2 2 0 12 Fair
103 Heyns, et al. (2011). South Africa 9 1 2 2 1 15 Good
104 Hien, et al. (2014). Burkina Faso 8 0 2 1 1 12 Fair
105 Hontelez, et al. (2011). South Africa 4 0 2 1 1 9 Fair
106 Houser, et al. (2016). Democratic Republic of Congo 9 2 2 1 1 15 Good
107 Huang, et al. (2020). China, Ghana, India, Russia, and South Africa 9 1 2 1 1 13 Good
108 Hughes, et al. (2013). South Africa. 8 0 2 1 0 11 Fair
109 Ibrahim, et al. (2015). Nigeria. 8 0 2 1 0 11 Fair
110 Igbokwe et al. (2020). Nigeria 8 2 2 2 1 14 Good
111 Jacobs et al. (1984). South Africa 7 3 2 2 1 14 Good
112 Jesus et al. (2013). Central African Republic and Republic of Congo. 3 2 2 1 1 12 Fair
113 Joffe et al. (1975). South Africa 9 0 2 0 1 11 Fair
114 Joska et al. (2019). South Africa 8 2 2 2 1 14 Good
115 Kailembo et al. (2017). China, Ghana, India, and South Africa 8 1 3 1 1 13 Good
116 Kakongi et al. (2020). Uganda 7 2 2 1 1 11 Fair
117 Kalu et al. (2019). Nigeria. 5 1 2 1 0 10 Fair
118 Kellett et al. (2021). Tanzania 7 1 2 1 0 4 Poor
119 Kimuna et al. (2007). South Africa 9 2 2 1 1 15 Good
120 Kiplagat et al. (2019). Kenya 6 1 1 2 1 11 Fair
121 Kinyanda et al. (2016). Uganda 7 0 2 2 1 13 Good
122 Klemz et al. (2015). South Africa 6 0 1 2 1 12 Fair
123 Kobayashi et al. (2019). South Africa 8 3 1 1 1 14 Good
124 Kolbe-Alexandar et al. (2006). South Africa 10 0 1 1 1 12 Fair
125 Kolbe-Alexandar et al. (2015). South Africa 9 0 1 1 0 12 Fair
126 Koyanagi et al. (2019). South Africa 9 0 1 1 0 11 Fair
127 Kunna et al. (2017). China, Ghana. 7 1 1 1 1 13 Good
128 Kuteesa et al. (2012). Uganda. 7 1 1 1 1 13 Good
129 Kuteesa et al. (2014). Uganda. 8 1 3 3 0 15 Good
130 Kyobutungi et al. (2009). Kenya 10 1 3 3 1 18 Good
131 Kyobutungi et al. (2010). Kenya 11 0 3 2 1 17 Good
132 Lambert et al. (2017). Ghana, India, and Russian 9 2 3 2 1 16 Good
133 Le Roux, et al. (2007). South Africa. 10 1 3 2 0 16 Good
134 Legesse et al. (2019). Ethiopia 11 1 3 4 1 20 Excellent
135 Lekpa et al. (2013). Senegal 9 2 3 2 1 17 Good
136 Lenger et al. (1996). South Africa 7 1 2 2 0 13 Good
137 Lewis et al. (2017). Tanzania 11 3 3 4 1 23 Excellent
138 Longdon et al. (2012). Tanzania 9 1 3 4 1 18 Good
139 Lowis et al. (1997). South Africa 7 0 0 0 0 18 Good
140 Lwanga et al. (2019). Uganda. 11 1 3 4 1 18 Good
141 Mabaso et al. (2016). South Africa 10 3 3 2 0 18 Good
142 Mabeku et al. (2020). Cameroon 9 0 3 3 0 18 Good
143 Macia et al. (2011). Senegal. 9 0 3 4 1 18 Good
144 Macia et al. (2012). Senegal. 9 0 3 3 1 18 Good
145 Macia et al. (2015). Senegal 7 0 3 2 1 18 Good
146 Maina Gatimu, Williesham Milimo & San Sebastian (2016). Ghana. 8 1 2 2 1 14 Good
147 Manlragaba et al. (2019). Uganda 9 1 3 3 1 17 Good
148 Maritz et al. (2018). South Africa. 11 1 3 4 1 20 Excellent
149 Martinez et al. (2014). South Africa. 10 2 3 3 1 19 Excellent
150 Matlho et al. (2019). Botswana 8 0 3 1 1 13 Good
151 Mbada et al. (2020). Nigeria. 10 0 3 1 0 14 Good
152 Mbui et al. (2017). Kenya 11 1 3 2 0 17 Good
153 McKinnon et al. (2013). Sub-Saharan African 11 3 3 4 1 23 Excellent
154 Mhaka-Mutepfa, et al. (2014). Zimbabwe 6 2 3 1 1 13 Good
155 Minicuci, et al. (2014). Ghana 5 1 3 0 1 10 Fair
156 Molete, et al. (2014). South Africa. 8 0 3 3 1 15 Good
157 Mtowa et al. (2017). Tanzania 9 2 3 0 1 15 Good
158 Mugisha, et al. (2015). Uganda 6 2 3 1 1 13 Good
159 Mugisha, et al. (2016). Uganda 9 1 3 2 1 15 Good
160 Mugisha, et al. (2017). Uganda 7 1 3 0 1 12 Fair
161 Mugisha, et al. (2020). Uganda 9 1 3 4 1 18 Good
162 Mwanyangala, et al. (2010). Tanzania 9 2 3 1 1 16 Good
163 Mworozi, et al. (2019). Uganda 9 2 3 1 0 15 Good
164 Myroniuk. (2017). Malawi. 7 3 3 3 1 17 Good
165 Nash, et al. (1983). South Africa. 9 2 2 3 1 17 Good
166 Negin, et al. (2010). Kenya. 10 2 3 2 1 18 Good
167 Negin et al. (2012a). South Africa 11 3 3 3 1 22 Excellent
168 Negin et al. (2012b). Malawi, Nigeria, Senegal, Rwanda & Tanzania 8 2 2 3 1 16 Good
169 Negin, et al. (2015). Uganda. 8 1 3 4 1 17 Good
170 Negin, et al. (2016). South Africa. 6 3 3 4 1 17 Good
171 Negin, et al. (2017). South Africa. 11 2 3 3 1 20 Excellent
172 Njemini, et al. (2002). Cameroon. 5 1 3 0 0 9 Fair
173 Njemini, et al. (2011). Cameroon. 8 1 3 2 1 15 Good
174 Nutakor et al. (2020). Ghana. 11 3 3 4 1 22 Excellent
175 Nwakasi, et al. (2019). Ghana. 10 1 2 1 1 17 Good
176 Nyanguru. (2007). Zimbabwe. 6 1 0 1 1 9 Fair
177 Nyirenda, et al. (2012). South Africa. 9 1 3 2 1 17 Good
178 Nyirenda, et al. (2012). Uganda and South Africa. 9 1 3 1 1 16 Good
179 Obuku, et al. (2013). Uganda. 8 2 3 2 0 15 Good
180 Ogun et al. (2021). Nigeria 10 2 3 3 1 19 Excellent
181 Ojagbemi et al. (2013). Nigeria. 10 3 3 4 1 21 Excellent
182 Okoye et al. (2020). Nigeria. 11 0 2 4 0 17 Good
183 Oladeji et al. (2011). Nigeria 11 3 3 4 1 22 Excellent
184 Olamoyegun e al. (2020). Nigeria. 11 2 3 4 0 20 Excellent
185 Olatayo et al. (2015). Nigeria 8 0 3 3 0 13 Good
186 Olusanya et al. (2019). Nigeria 9 3 3 3 0 18 Good
187 Omenai et al. (2020). Nigeria 8 3 3 3 1 18 Good
188 Onadja et al. (2013). Burkina Faso 11 3 3 4 1 22 Excellent
189 Onakpoya et al. (2021). Nigeria. 10 0 3 3 0 16 Good
190 Onwuchekwa et al. (2009). Nigeria. 9 3 2 3 0 17 Good
191 Osberg. (2014). Tanzania. 10 3 3 4 1 21 Excellent
192 Ottie-Boakye. (2020). Ghana 11 3 3 4 1 22 Excellent
193 Oyeyemi et al. (2019). Nigeria. 11 3 3 4 1 22 Excellent
194 Oyeyemi et al. (2020). Nigeria. 11 3 3 4 1 22 Excellent
195 Padayachey et al. (2017). South Africa 11 3 3 4 1 22 Excellent
196 Paddick et al. (2015). Tanzania. 11 3 3 4 0 21 Excellent
197 Paddick et al. (2018). Tanzania 11 3 3 4 1 22 Excellent
198 Paquissi et al. (2016). Angola 9 0 3 3 0 15 Good
199 Parmar et al. (2014). Ghana and Senegal 7 2 0 2 1 12 Fair
200 Payne et al. (2017). South Africa. 6 2 2 2 1 13 Good
201 Peil et al. (1988). Nigeria. 1 2 2 2 1 8 Fair
202 Peltzer and Phaswana-Mafuya. (2012a). South Africa 5 0 1 2 1 9 Fair
203 Peltzer and Phaswana-Mafuya. (2012b). South Africa 6 3 2 2 1 14 Good
204 Peltzer and Phaswana-Mafuya. (2013a). South Africa 5 3 2 2 1 13 Good
205 Peltzer and Phaswana-Mafuya. (2013b). South Africa 6 3 2 2 1 14 Good
206 Peltzer and Phaswana-Mafuya. (2013c). South Africa 6 3 2 2 1 14 Good
207 Peltzer and Phaswana-Mafuya. (2014). South Africa 6 3 2 2 1 14 Good
208 Peltzer and Phaswana-Mafuya. (2017). South Africa 6 3 2 2 1 14 Good
209 Peltzer and Pengpig. (2018). South Africa 5 3 2 2 1 13 Good
210 Peltzer and Phaswana-Mafuya. (2012c). South Africa 6 3 2 2 1 14 Good
211 Peltzer and Phaswana-Mafuya. (2012d). South Africa 5 3 2 2 1 13 Good
212 Peltzer and Phaswana-Mafuya. (2013d). South Africa 5 3 2 2 1 13 Good
213 Peltzer. (2012). South Africa 6 3 2 2 1 14 Good
214 Peltzer. (2017). South Africa 6 3 2 2 1 14 Good
215 Pengpid and Peltzer. (2019). South Africa 8 3 2 3 1 16 Good
216 Perold and Muller. (2000). South Africa 4 3 1 2 1 11 Fair
217 Pfttifor et al. (1978). South Africa 3 0 0 2 0 5 Poor
218 Phaswana-Mafuya and Peltzer. (2018). South Africa 8 3 2 2 1 15 Good
219 Phaswana-Mafuya et al. (2013a). South Africa 6 3 2 2 1 14 Good
220 Phaswana-Mafuya et al. (2013b). South Africa 6 3 2 2 1 14 Good
221 Phukubye and Oyedele. (2011). South Africa 3 0 2 0 0 5 Poor
222 Pieterse et al. (2002). Rwanda. 6 3 2 2 1 14 Good
223 Pilleron et al. (2015a). Central African Republic 9 2 2 2 1 16 Good
224 Pilleron et al. (2015b). Central African Republic 9 2 2 3 1 17 Good
225 Pilleron et al. (2015c). Central African Republic 9 2 2 3 1 17 Good
226 Pilleron et al. (2017). Central African Region. 7 3 2 2 1 15 Good
227 Pilleron et al. (2019). Kenya, South Africa, Uganda, and Zimbabwe 5 3 2 2 1 13 Good
228 Preux et al. (2014). Central African Republic & Republic of Congo 8 1 1 1 1 12 Fair
229 Prinsloo et al. (1991). South Africa 4 2 1 2 1 10 Fair
230 Puckree et al. (1997). South Africa 4 2 2 2 1 11 Fair
231 Raal et al. (2013). South Africa 5 1 2 2 1 11 Fair
232 Raal et al. (2011). South Africa 5 3 2 2 1 13 Good
233 Rabie et al. (2015). South Africa 5 3 2 2 0 12 Fair
234 Ralston. (2018). South Africa 7 2 2 2 1 14 Good
235 Ralston. (2015). South Africa 6 2 2 1 1 12 Fair
236 Ramjeeth. (2008). South Africa 6 2 2 2 1 13 Good
237 Ramlagan et al. (2013). South Africa 8 3 2 2 1 15 Good
238 Ramlagan et al. (2014). South Africa 7 3 2 2 1 15 Good
239 Ramocha et al. (2016). South Africa 7 3 2 2 0 14 Good
240 Randall & Coast. (2016). Sub-Saharan Africa 5 3 2 2 1 14 Good
241 Ranjith et al. (2016). South Africa. 8 3 0 2 1 14 Good
242 Rayner et al. (2007). South Africa 7 2 2 2 1 14 Good
243 Reddy et al. (1985). South Africa 5 2 2 2 1 12 Fair
244 Robb et al. (2017). South Africa 5 3 2 2 1 13 Good
245 Rossouw and Smith. (2017). South Africa 5 2 2 1 1 11 Fair
246 Rotchford and Johnson. (2000). South Africa 5 2 1 0 0 8 Poor
247 Rotchford et al. (2002). South Africa 7 2 3 2 1 15 Good
248 Rotchford et al. (2003). South Africa 5 2 2 0 1 10 Fair
249 Rotchford, Alan, and Johnson. (2017). South Africa 5 2 1 0 1 9 Fair
250 Rodriguez. (2002). South Africa 4 2 2 1 0 0 Poor
251 Saeed et al. (2016). Ghana. 4 2 2 0 1 9 Poor
252 Saka et al. (2019). Nigeria and South Africa. 4 1 0 1 0 6 Poor
253 Samba et al. (2019). Republic of Congo 8 2 2 1 1 13 Good
254 Sarfo et al. (2020). Ghana 3 0 1 0 0 4 Poor
255 Sarkodie et al. (2020). Ghana. 7 1 1 2 0 11 Poor
256 Schatz et al. (2012). South Africa 5 0 0 0 0 5 Poor
257 Schatz et al. (2015). South Africa 7 1 1 1 0 10 Fair
258 Schmidlin et al. (2018). South Africa 4 0 2 0 0 6 Poor
259 Scholten et al. (2011). South Africa 6 0 2 0 0 8 Fair
260 Segal et al. (1980). South Africa 3 2 1 0 1 7 Poor
261 Silbert. (1977). South Africa 2 1 0 0 0 3 Poor
262 Simo et al. (2020). Cameroon 9 2 2 3 0 16 Good
263 Singo et al. (2015). South Africa. 4 0 1 0 1 6 Poor
264 Smith & Grove. (2009). South Africa. 6 0 2 2 1 11 Fair
265 Solomon et al. (1982). South Africa 5 1 2 1 0 9 Fair
266 Somdyala et al. (2010). South Africa. 7 3 2 1 1 14 Good
267 Ssensamba et al. (2019). Uganda 8 2 2 2 0 14 Good
268 Ssonko et al. (2017). Uganda 8 3 3 2 1 17 Good
269 Surka & Hussain. (2001). South Africa. 7 3 2 2 1 15 Good
270 Tanor et al. (2017). South Africa 9 2 2 3 0 16 Good
271 Tarekgne et al. (2017). Ghana and South Africa 8 3 2 2 1 16 Good
272 Tegegn et al. (2019). Ethiopia 8 2 2 3 0 15 Good
273 Till et al. (1999). South Africa 7 2 3 2 0 15 Good
274 Tipping et al. (2006). South Africa 9 3 3 3 1 18 Good
275 Togonu-Bickersteth et al., 1986, Nigeria 7 3 3 2 1 16 Good
276 Tolani et al. (2020). Nigeria. 5 2 2 0 0 9 Fair
277 Tomas et al. (2012). Angola 10 3 2 3 1 19 Excellent
278 Toure et al. (2012). Senegal 11 2 3 1 1 18 Good
279 Tumaini et al. (2019). Tanzania 11 3 3 2 1 20 Excellent
280 Uwakwe et al. (2009). Nigeria 10 2 2 2 1 17 Good
281 Uys and Hunt. (1990). South Africa 6 1 0 0 0 7 Poor
282 Van Biljon et al. (2015). South Africa 11 2 3 1 0 17 Good
283 van der Pas et al. (2015). South Africa. 10 2 3 1 1 17 Good
284 van Rensburg et al. (2017). South Africa 11 2 0 0 0 14 Good
285 Van Wyk et al. (1997a). South Africa 9 3 3 4 1 20 Excellent
286 Van Wyk et al. (1997b). South Africa 9 3 3 4 1 20 Excellent
287 Walker et al. (1989). South Africa 9 1 3 4 0 17 Good
288 Walker et al. (1999). South Africa 9 0 3 4 0 16 Good
289 Wandera, Golaz, Kwagala & Ntozi. (2015). Uganda 10 3 3 4 1 21 Excellent
290 Wandera, Ntozi & Kwagala. (2014). Uganda 9 3 3 4 1 20 Excellent
291 Wandera, Ntozi & Kwagala. (2015). Uganda 9 3 3 4 1 20 Excellent
292 Werfalli et al. (2018). South Africa 10 3 3 4 1 21 Excellent
293 Wessels & Riback. (2012). South Africa 9 3 3 4 1 21 Excellent
294 Westaway. (2010a). South Africa 8 3 3 4 1 19 Excellent
295 Whitelaw et al. (1994). South Africa 4 0 2 3 0 9 Fair
296 Williams et al. (2015). South Africa 6 0 2 2 1 11 Fair
297 Wilunda et al. (2015). Kenya 6 3 2 2 1 14 Good
298 Wolff. (1978). South Africa 6 1 2 2 0 11 Fair
299 Xavier Gómez-Olivé et al. (2010). South Africa 7 3 3 3 1 17 Good
300 Zimmer & Dayton. (2005). 25 Sub-Saharan African countries. 7 3 2 3 1 16 Good

Quality assessment of case reports. Table 6 shows the quality assessment of 4 case reports; all were rated as moderate quality reporting.

Quality assessment of qualitative studies. We presented the quality assessment result of the 74 qualitative studies in Table 7. We rated 19 as high-quality qualitative studies, 37 as moderate-quality, and 18 as low-quality qualitative studies. The domain with the least score was ‘Research team and reflexivity’, with one-third of the studies scoring above average.96–117 However, only three studies scored below average in the ‘study design’85,118,119 and ‘analysis and findings’85,119,120 domains.

Quality assessment for mixed-method studies. We also assessed the quality of fifteen mixed-method studies (Table 8). Most of the studies (n=12, 80%) were rated high MMAT studies, and three were low MMAT studies.121–123 Across the three low MMAT studies, one had poor scores in the quantitative domain,122 and the other two had poor qualitative domains.121,123 In terms of the MMAT appraisal criteria, four studies did not satisfy the Justification criterion,121–124 three studies did not satisfy the Integration criterion,121–123 and six studies satisfied the Disagreement criterion.121–123,125,126 Five studies did not satisfy the Interpretation criterion121–123,126,127 and Adherence criterion.121–123,126–128

Table 6.Quality Assessment of Case reports (n = 4), using the CAse REport (CARE) guidelines checklist.16
S/N Name of authors, Year of publication, Country Title/1 Keyword/1 Abstract/5 Intro/1 PI/4 CF/1 Ti/1 DA/4 TI/3 FC/4 Disc /4 Pp/IF/ 2 Total (/31) / Interpretation
1 Amod et al. (2005). South Africa 1 1 5 1 3 1 0 3 2 1 4 1 23/Moderate
2 Jingi et al. (2017). Sub-Saharan Africa 1 1 5 1 4 1 0 2 2 0 4 1 22/Moderate
3 Rajak et al. (2009). West Africa (Nigeria, Sierra Leone, Ghana) 1 0 5 1 3 1 0 2 2 0 4 1 20/Moderate
4 Sobnach et al. (2009). South Africa 1 1 5 1 3 1 0 2 2 0 4 0 20/Moderate

Notes: PI - Patient information; CF - clinical finding; Ti - Timeline; DA - Diagnostic Assessment; TI - Therapeutic intervention; FC - follow-up and controls; Disc - Discussion; PP/IF - Patient perspective/Informed consent

Table 7.Quality Assessment of Qualitative studies (n = 75), using the 45-items Lundgren et al.17
S/N Name of authors, Year of publication, Country Domain 1: Research team and reflexivity (/8) Domain 2: Scope and purposes (/2) Domain 3: study design (/17) Domain 4: analysis and findings (/14) Domain 5: Relevance and transferability (/4) Total score (/45)/interpretation
1 Aboderin, I. (2004). Ghana 2 2 11 13 4 32/Moderate
2 Adam, A., & Koranteng, F. (2020). Ghana 4 2 15 9 4 34/Moderate
3 Adandom, I. et al. (2020). Nigeria 7 2 17 14 4 44/High
4 Agunbiade, O. M., & Akinyemi, A. I. (2016). Nigeria 7 2 16 13 4 42/High
5 Agunbiade, O. M., & Ayotunde, T. (2012). Nigeria 4 2 17 12 4 39/High
6 Agyemang-Duah, W., Arthur-Holmes, F., Peprah, C., Adei, D., & Peprah, P. (2020). Ghana 4 2 15 12 4 37/Moderate
7 Agyemang-Duah, W., Peprah, C., & Peprah, P. (2019). Ghana 6 2 16 13 4 41/High
8 Agyemang-Duah, W., Peprah, C., & Peprah, P. (2019). Ghana 4 2 16 13 4 39/High
9 Akinrolie, O., Okoh, A. C., & Kalu, M. E. (2020). Nigeria 8 2 17 14 4 45/High
10 Alidu, L., & Grunfeld, E. A. (2020). Ghana 6 2 12 11 4 35/Moderate
11 Angotti, N., Mojola, S. A., Schatz, E., Williams, J. R., & Gómez-Olivé, F. X. (2018). South Africa 3 2 14 13 2 34/Moderate
12 Atata, S. N. (2019). Nigeria 2 2 10 7 4 25/Low
13 Ayokunle, M et al. (2015). Nigeria 1 2 4 6 2 15/Low
14 Bayuo, J. (2017). Ghana 7 2 16 12 4 41/Moderate
15 Bohman, D. M., Van Wyk, N. C., & Ekman, S. (2014). South Africa 5 2 14 11 4 37/Moedrate
16 Bohman, D. M., Van Wyk, N. C., & Ekman, S. L. (2009). South Africa 5 2 16 11 3 37/Moderate
17 Bohman, D. M., van Wyk, N. C., & Ekman, S. L. (2011). South Africa 4 2 16 12 4 38/Moderate
18 Bohman, Doris M., Vasuthevan, S., Van Wyk, N. C., & Ekman, S. L. (2007). South Africa 7 2 16 14 4 43/High
19 Cadmus, E. O., Adebusoye, L. A., Olowookere, O. O., Olusegun, A. T., Oyinlola, O., Adeleke, R. O., ... & Alonge, T. O. (2019). Nigeria 3 2 16 10 4 35/Moderate
20 Cadmus, E. O., Owoaje, E. T., & Akinyemi, O. O. (2015). Nigeria 3 2 16 13 4 38/Moderate
21 de Klerk, J., & Moyer, E. (2017). Camerron 3 2 15 13 3 36/Moderate
22 Diameta, E., Adandom, I., Jumbo, S. U., Nwankwo, H. C., Obi, P. C., & Kalu, M. E. (2018). Nigeria 5 2 17 13 4 41/High
23 Golaz, V., Wandera, S. O., & Rutaremwa, G. (2017). Uganda 0 2 5 0 4 11/Low
24 Hien, H et al., (2015). Burkina Faso 4 2 9 5 2 22/Low
25 Howorth, K., Paddick, S. M., Rogathi, J., Walker, R., Gray, W., Oates, L. L., ... & Dotchin, C. (2019). Tanzania 6 2 14 12 4 40/High
26 Kakongi, N., Rukundo, G. Z., Gelaye, B., Wakida, E. K., Obua, C., & Okello, E. S. (2020). Uganda 4 2 16 12 4 38/Moderate
27 Kelly, G., Mrengqwa, L., & Geffen, L. (2019). South Africa 5 2 17 14 4 42/High
28 Kerr, P. P., & Schulze, S. (2004). South Africa 3 2 13 11 4 33/Moderate
29 Kiplagat, J., Mwangi, A., Chasela, C., & Huschke, S. (2019). Kenya 3 2 13 10 4 32/Moderate
30 Knight, L., Schatz, E., & Mukumbang, F. C. (2018). South Africa 3 2 12 11 4 32/Moderate
31 Kuteesa, M. O., Seeley, J., Cumming, R. G., & Negin, J. (2012). Uganda 1 2 13 8 4 28/Low
32 Lekalakala-Mokgele, E. (2014). South Africa 6 2 12 9 3 32/Moderate
33 Lekalakala-Mokgele, E. (2016). South Africa 6 2 13 12 3 36/Moderate
34 Leuning, C., Small, L., & Van Dyk, A. (2000). Namimbia 5 2 15 11 2 32/Moderate
35 Lopes Ibanez-Gonzalez, D., & Tollman, S. M. (2015). South Africa 6 2 16 13 4 41/High
36 Matovu, S. N., & Wallhagen, M. I. (2020). Uganda 6 2 13 12 4 37/Moderate
37 Matovu, S., Rankin, S., & Wallhagen, M. (2020). Uganda. 2 2 14 11 4 33/Moderate
38 Mkhonto, F., & Hanssen, I. (2018). South Africa 4 2 14 12 4 36/Moderate
39 Moroe, N., & Vazzana, N. (2019). South Africa 0 2 10 11 3 26/Low
40 Muchiri, J. W., Gericke, G. J., & Rheeder, P. (2012). South Africa 7 2 16 14 4 43/High
41 Mushi, D., Rongai, A., Paddick, S. M., Dotchin, C., Mtuya, C., & Walker, R. (2014). Tanzania. 1 2 11 13 4 31/Moderate
42 Nadasen, K. (2008). South Africa 4 2 11 12 3 32/Moderate
43 Naidoo, K., & Van Wyk, J. (2019). South Africa 2 2 13 8 4 29/Low
44 Ntuli, M., & Madiba, S. (2019). South Africa 1 2 12 12 3 30/Low
45 Nwankwo, H. C., Akinrolie, O., Adandom, I., Obi, P. C., Ojembe, B. U., & Kalu, M. E. (2019). Nigeria. 3 2 13 12 4 34/Moderate
46 Obi, P. C., Nwankwo, H. C., Emofe, D., Adandom, I., & Kalu, M. E. (2019). Nigeria 5 2 14 14 4 39/High
47 Ojembe, B. U., & Kalu, M. E. (2018). Nigeria. 2 2 14 13 4 35/Moderate
48 Ojembe, B.U. & Kalu, M. E. (2019). Nigeria. 3 2 14 14 4 37/Moderate
49 Okoh, A. E., Akinrolie, O., Bell-Gam, H. I., Adandom, I., Ibekaku, M. C., & Kalu, M. E. (2020). Nigeria 2 2 14 13 4 35/Moderate
50 Richards, E., Zalwango, F., Seeley, J., Scholten, F., & Theobald, S. (2013). Uganda 1 1 8 8 2 20/Low
51 Roos, V., & Klopper, H. (2010). South Africa 7 2 16 12 4 42/High
52 Roos, V., & Malan, L. (2012). South Africa 1 2 13 12 4 32/Moderate
53 Roos, V., Keating, N., & Kahl, C. (2019). South Africa 7 2 15 12 4 40/High
54 Roos, V., Kolobe, P. S., & Keating, N. (2014). South Africa 1 2 11 13 4 31/Moderate
55 Roos, V., & Wheeler, A. (2016). South Africa. 2 2 12 13 2 31/Moderate
56 Roos, V., Silvestre, S., & De Jager, T. (2017). South Africa. 0 2 11 13 3 29/low
57 Rotchford, A. P., Rotchford, K. M., Mthethwa, L. P., & Johnson, G. J. (2002). South africa. 5 2 16 13 3 39/High
58 Rutagumirwa, S. K., & Bailey, A. (2019). Tanzania 3 2 13 13 4 35/Moderate
59 Schatz, E. J. (2009). South Africa 4 2 10 10 3 29/Low
60 Schatz, E., & Gilbert, L. (2014). South Africa 3 2 10 9 4 28/Low
61 Schatz, E., & Knight, L. (2018). South Africa 2 2 11 13 4 32/Moderate
62 Schatz, E., Seeley, J., Negin, J., Weiss, H. A., Tumwekwase, G., Kabunga, E., Nalubega, P., & Mugisha, J. (2019). Ugandans. 4 2 13 14 4 37/Moderate
63 Sidloyi, S. S., & Bomela, N. J. (2016). South Africa 1 2 13 13 4 33/Moderate
64 Singo, V. J., Lebese, R. T., Maluleke, T. X., & Nemathaga, L. H. (2015). South Africa 1 2 14 13 4 34/Moderate
65 Skovdal, M., Campbell, C., Madanhire, C., Nyamukapa, C., & Gregson, S. (2011). zimbabwe 1 2 11 10 3 27/Low
66 Ssengonzi, R. (2007). Uganda 5 2 16 13 4 40/High
67 Tanyi, P. L., Pelser, A., & Okeibunor, J. (2018). Cameroon 7 2 15 13 4 41/High
68 Udvardy, M & Cattell, M (1992). South Africa 2 1 3 2 1 9/Low
69 van Biljon, L., Roos, V., & Botha, K. (2015). South Africa 0 2 9 8 3 22/Low
70 Van Der Geest, S. (2002). Ghana 4 1 11 5 2 23/Low
71 Van Der Geest, S. (2004). Ghana 4 2 14 11 2 33/Moderate
72 Van Dongen, E. (2003). South Africa 2 2 6 6 3 19/Low
73 Van Dongen, E. (2005). South Africa 3 1 4 3 2 13/Low
74 Wilkinson, M., & Vember, H. (2013). South Africa 1 3 15 13 4 36/Moderate
Table 8.Quality Assessment of Mixed-method studies (n = 15), using the Mixed Method Appraisal Tool.18
S/N Name of authors, Year of publication, Country Qualitative component score (%)/rating Quantitative component score (%)/rating Mixed methods/integration
rating Justification Integration Interpretation Disagreement Adherence
1 Afolabi et al., 2019/Nigeria 100/high 80/ high High Yes Yes Can't tell No Yes
2 Deist et al., 2017/South Africa 100/high 100/high High Yes Yes Yes Yes Yes
3 Drah, 2014/Ghana & South Africa 100/high 80/ high High No Yes Yes Yes Yes
4 Frost, 2015/Sub-Saharan Africa 80/ high 80/ high High Yes Yes Yes Yes Can't tell
5 Geyer, 2010/South Africa 100/high 100/high High Yes Yes Yes Yes Yes
6 Kuteesa et al., 2014/Uganda 100/high 100/high High Yes Yes Yes Yes Yes
7 Naah et al., 2020/Cameroon 100/high 100/high High Yes Yes Yes Yes Yes
8 Ndou et al., 2013/South Africa 100/high 80/ high High Yes Yes Yes Yes Yes
9 Peltzer, 2004/South Africa 80/ high 80/ high High Yes Yes Yes Yes Yes
10 Phillips-Howard et al., 2014/Kenya 100/high 100/high High Yes Yes Yes Yes Yes
11 Pienaar et al., 2010/South Africa 0/ low 80/ high Low No No No No No
12 Rhoda et al., 2015/South Africa 100/high 80/ high High Yes Yes Yes No Yes
13 Schatz, 2007/South Africa 100/high 0/ low Low Can’t tell No No No No
14 Semeere et al., 2014/Uganda 0/ low 100/high Low No No No No No
15 Watson et al., 2013/South Africa 80/ high 100/high High Yes Yes No No Can't tell

DISCUSSION

This article is the second in a Four-Part series6 to describe the quality (methodological quality and reporting quality) of ageing-related peer-review articles in the SSA. The methodological and quality reporting of published studies relating to ageing in SSA showed variable quality, albeit primarily good quality, suggesting room for improvement, especially for RCTs. The quality assessment provides information on the overall strength of evidence and methodological quality of a research design, conduct and analysis, highlighting the level of confidence the reader should place on the findings for decision making. It is important to note that, even though the quality is generally good, the quality assessment reflects more on the quality of reporting rather than the methodological qualities (bias assessment) used in the included studies. Because of limited word counts and lack of use of reporting guidelines across the included article, it was challenging to assess the methodological qualities of the included articles. The first step to allow for practical methodological qualities assessment is encouraging ageing researchers in SSA to adopt reporting guidelines for any study design (See https://www.equator-network.org, for different reporting guidelines). After achieving this (ageing researchers using reporting guidelines to report their article), we can practically assess the methodological qualities (biases) that could reduce the reader’s confidence in the findings for decision-making.

Previous studies have argued that poor-quality research, either quality or methodology reporting in the SSA, is somewhat related to poor quality data on surveys or objective measures, such as incomplete reporting.129 Generally, the unreliability of the data may be caused by sampling in the developing world, such as convenience sampling, which limits generalization, thereby impeding the use of such information in making a national or regional policy decision. Although the issue of sample size may not be specific to the ageing research in SSA, sample sizes were generally small in most studies included in our review. This highlighted the importance of longitudinal studies with an extensive data set and its accessibility for SSA researchers. Although longitudinal studies on ageing in the SSA region are increasing, pockets of community data sets in different forms are extensive, as shown in the articles included in this review. Therefore, global organizations, such as World Health Organisation-Ageing Africa or HelpAge-Africa, should create a data depository specific to ageing studies and develop standards/requirements to encourage researchers in different regions of Africa to deposit their study data. To guide against depositing poor quality or incomplete data, researchers depositing their collected data should clearly describe how it is collected. In addition, a committee should be commissioned to oversee and manage the data deposition; such a committee could be housed in already established centres for longitudinal studies, for instance, the WHO - SAGE collection centres in Ghana and South Africa. We recommend a standard data deposition reporting guideline for researchers, as it is promising to guide the researchers in providing a detailed description of their data collection methods. Besides, this checklist will guide the committee in reviewing and deciding which data should be deposited. To encourage researchers, any data deposit will be compensated with a fee. These data should be made available for researchers to answer different research questions and promote the global concept of data accessibility.

Could the implementation of National ageing policies in some African countries or the training and research in geriatric or gerontological have influenced the quality of ageing studies in this review? While we cannot measure this quantitatively, we could argue that it may indirectly impact the quality of studies. Currently, eleven countries, including South Africa, Ghana, Mozambique, Uganda, Tanzania, Zimbabwe, Kenya, Ethiopia, Malawi, and Nigeria, have implemented ageing policies.130,131 These countries relatively have the highest number of high-quality articles across all study design; for instance, Nigeria: 62,93,108; South Africa: 24,64,117,132,133; Tanzania: 116,134,135; Mozambique: 136; Kenya: 137,138; Ethiopia: 139; Uganda: 140–142; Ghana: 143–145. Even though Rwanda and Cameroon’s ageing policies are at the drafting stage, studies from these countries were not of high quality and further highlighted our assertion that implementing ageing policies could help improve the quality of ageing studies in SSA. Nevertheless, there is a need to critically evaluate the impact of ageing policies on the quality of ageing studies. Furthermore, SSA countries with training and research in gerontology and geriatrics, and funding, such as South Africa,125,146 have the expertise to produce high-quality studies. This highlights the importance of geriatric and gerontological training and its potential impact on Africa’s quality of ageing research. Since training and research in gerontology and geriatrics are hardly supported by the governments in SSA,130 strategies to ensure adequate and continuous training in gerontology and geriatrics are recommended.

We observed that majority of the RCT/quasi-experimental studies (n=12/15, 80%) were conducted in South Africa, including one rated excellent and two rated good. The remaining two quasi-experimental studies were conducted in Nigeria and Kenya and were rated good. We also noticed that South African studies with ratings ranging between excellent and good were published in journals whose impact factors were higher (0.66 - 4.38) than studies from other countries with similar ratings published in 0.51 - 2.61 journals. This finding raises some questions to be considered by researchers and higher education institutions in SSA. First, could the dominance of South African studies within the RCT category be a function of the researchers’ training or knowledge in this design? Second, do more South African studies having better ratings (excellent and good) imply that the researchers better know the methods and feasibility of conducting RCTs or quasi-experimental research? Third, could the low representation of some SSA countries and the absence of others within this study category imply a lack of training of researchers or inadequate knowledge in this study design? Fourth, could it also be a function of resource-setting in terms of funding available for research? For instance, high-resource setting (in the case of South Africa) versus low resource-setting (in the case of other SSA countries). These questions are important areas to explore to understand better or highlight the discrepancies in the quality reporting of ageing studies in SSA.

While RCTs are considered the highest level of evidence for decision-making,147 the cost of planning and managing RCTs is often high, limiting the number of high-quality RCTs in the SSA areas. Scholars have argued that non-RCTs can also provide substantial evidence, especially if they are of high-quality study design.148 Both RCTs and non-RCTs are important in examining cause-effect relationships between an intervention and outcome; however, non-RCTs cannot eliminate the possibility of mediating factors in the outcomes. Where funding is an issue in developing and conducting RCTs, we encourage ageing researchers to plan quasi-experimental studies employing and describing the methodology using a reporting guideline to assess the methodological biases efficiently.

We observed moderate to low-quality qualitative ageing studies conducted in SSA. These low reporting qualities ranged from not reporting qualitative study type, sampling, and poor strategies reporting to ensure rigour. This information is needed to allow readers a logical process that will add credibility to the findings informing policies. Most studies did not provide a thick description of their methodology, making the study’s replicability in another setting challenging; this further doubts the study findings limiting its use in making clinical and policy decisions. Member checking, peer debriefing, data triangulation, and reflexive statement of the research team’s characteristic and how it influences data collection and analysis were lacking in most qualitative studies. Qualitative ageing research in SSA is increasing and has been under intense scrutiny for its methodology and reporting, hindering its use in clinical practice.149 Therefore, qualitative ageing researchers use some of the qualitative reporting guidelines, such as consolidated criteria for reporting qualitative research (COREQ),150 standards for reporting qualitative research (SRQR),151 or Lundgren et al.'s17 45 checklist, is encouraged.

While the debates on quantitative research’s relative merits versus qualitative research are unending,152 researchers are encouraged to use both. Remarkably, 80% of mixed-method studies were high MMAT studies, and for the remaining 20%, the deficiency mainly was in qualitative studies, highlighting the need for training of qualitative ageing researchers in the SSA region. We should not celebrate this success story yet, since only 15 mixed-method studies were included and assessed in this review—a focused review on studies that utilized a mixed-method approach is warranted to either support to refute this success story.

While this is the first study to assess the quality of ageing research in SSA, it has some limitations. Even though our study strategy is robust, we may have missed some articles since some of the national Journals in SSA are not indexed in PubMED or related databases,153 and access to African Journal Online [https://www.ajol.info/index.php/ajol], which houses most journals in SSA region is limited. This study did not include articles published in languages other than French and English; some articles may have been missed in several African languages like Afrikaans and Hausa. While we conducted the quality assessment in pairs and used the mean scores for reporting, there is still the possibility of quality assessment bias since quality assessment tools are inherently biased because of their subjective nature. We believed that using quality assessment tools for specific study designs would have yielded different ratings. For instance, using COCHRANE Risk of Bias tools154 for RCT would have yielded different quality ratings.

We conclude that the methodological and quality reporting of published studies on ageing in SSA show variable quality, albeit primarily good quality, against excellent quality. Studies with a large sample size are recommended, and qualitative researchers should provide a section on research team members’ characteristics and reflexivity in their paper or as an appendix. Since this is the first study that describes the quality of published studies on ageing in SSA, a repeat quality assessment should be performed in the next decade. This paper is Part 2 of Kalu et al.'s6 review, and Part 3 of the paper will focus on a review of longitudinal studies of ageing in SSA, identifying areas that require longitudinal studies to explain the cumulative advantages and disadvantages across life course trajectory for the older adults population in the SSA region.


Acknowledgements

We want to acknowledge other members of the Emerging Researchers & Professionals in Ageing - African Network.

Funding

None.

Authors contributions

All authors contributed to the conceptualization, data screening, inclusion and extraction and manuscript drafting. All authors reviewed and approved the final manuscript for publication.

Competing interest

The authors completed the Unified Competing Interest form (available upon request from the corresponding author) and declare no conflicts of interest.